Monday, December 7, Vilnius – President Dalia Grybauskaitė opened new premises of Thermo Fisher Scientific in Vilnius, which produces magnetic beads that should become a serious antidote in the fight against oncological diseases and HIV. Lithuania is the first and currently the only country in the world starting to produce technological products of such level.
“Products created by Lithuanian scientists open up new opportunities to fight diseases that are killing the world. This is the best proof that our people are using their competences and knowledge not only to solve global problems but also to save humanity and contribute to an enormous technological revolution,” the President said.
State-of-the-art technology set up in the unique laboratory will enable Lithuanian scientists to pave the way for innovative treatment – personalized cell therapy. Products manufactured in our country will be used in therapies adapted to each patient personally. The use of these therapies will make the fight against cancer, HIV and autoimmune diseases far more effective and simple.
Magnetic beads coated with antibodies stimulate the patient’s lymphocytes, which start to proliferate. These cells will be additionally reprogrammed and re-implanted in the same patient’s body, which will recognize and destroy cancer cells. This method is expected to replace conventional treatments for cancer, e.g. chemotherapy, in the future.
According to the President, it is the acknowledgement of the whole of Lithuania that the manufacturing of the most innovative products is coming to our country. Dalia Grybauskaitė emphasized that Lithuania is increasingly establishing itself as an advanced, knowledge-based economy, creating world-class science and innovation.
Thermo Fisher Scientific, which started operating in our country five years ago, is a leader in the biotechnology market and among the largest companies in the world, manufacturing products designed for life sciences research and diagnostics. Products made in Lithuania are used all over the world in the fields of studying the structure of genes and developing new methods for diagnosing congenital, inherited and communicable diseases.
Thermo Fisher Scientific Vilnius Site employs 570 staff. It has one of the largest private research centers in the Baltic region.
Last updated 2015.12.07 12:51Back